Moderna says it will start developing a monkeypox vaccine


Moderna Inc. MRNA, -4.98% tweeted Monday afternoon that it is “investigating potential monkeypox vaccines at a preclinical level.” Several stocks of companies that are developing or have smallpox or monkeypox vaccines and treatments jumped in trading on Monday as more people have become aware of the cluster of cases in Europe. Moderna’s stock is down 48.3% so far this year, while the broader S&P 500 SPX, -1.95% has declined 16.6%.

This article was originally published by Read the original article here.

Previous articleThe Ratings Game: Snap stock plunges toward worst drop on record as profit warning makes the shares ‘uninvestible’
Next articleFDA to review Pfizer and Moderna vaccines for kids under 5 on June 15


Please enter your comment!
Please enter your name here